- This event has passed.
Combination Products: Finding Pathways to Market When Both Drug and Device Systems Are in Play
April 7, 2021 @ 4:00 pm - 6:00 pm EDT
Apr 7, 2021
4:00 – 6:00 PM (EDT)
Finding pathways to market when both drug and device systems are in play
Successful commercialization of combination products is an exciting, profitable growth arena for innovative concepts.
Estimated Market Size in 2024
= $178 Billion (CAGR 7.9%)
Source: Grand View Research
But how to do it right?
Our panelists will share their critical knowledge and experience with you. Hear their talks & then speak with them afterwards in post-Forum Networking!
Many significant advances in disease treatment come from combination products, which enable delivery of drugs in a more precise, controlled way.
You will learn about:
- Real life experiences of combination product startups
- Talking to investors
- Reimbursement strategies
- Navigating FDA regulatory challenges and roadblocks
- Finding success in a system designed for drug and devices, but not necessarily combined
Wed, April 21
4:00 – 6:00 PM (EST)
4:00 – 4:30 General Networking
4:30 – 5:30 Presentations
5:30 – 6:00 ‘Meet the Speakers’ & More Networking
$0 – Members (all categories)
$0 – Sponsors / Student
$0 – Covid Hardship
$20 – Non-Member
ACT is developing a combo product for non-resectable pancreatic cancer.
Topic: Firsthand account of the challenges unique to early-stage combination product companies, such as talking to investors.
Topic: How to navigate the regulatory landscape for combination products, what makes them different, and how to (hopefully) avoid pitfalls.
Topic: Reimbursement–what is needed for success with combination products.
Elazer R. Edelman
Director, Institute of Medical Engineering and Science, Director, Clinical Research Center at MIT; Current occupant of the Edward J. Poitras Chair as Professor of Medical Engineering and Science
April 7, 2021 Forum
Highlights Preview Short – Watch on Vimeo